Research Article
Does Isoniazid Preventive Therapy Provide Better Treatment Outcomes in HIV-Infected Individuals in Northern Ethiopia? A Retrospective Cohort Study
Table 1
Baseline sociodemographic and clinical characteristics of patients living with HIV/AIDS in Northern Ethiopia, 2009–2017.
| | Variables | Exposure to IPT | | No (ART alone) | Yes (IPT and ART) |
| | Sex | Male | 500 (69.2%) | 223 (30.8%) | | Female | 742 (65.1%) | 398 (34.9%) | | Age (in years) | <15 | 75 (63.0%) | 44 (37.0%) | | 15–29 | 235 (70.4%) | 99 (29.6%) | | 30–44 | 698 (65.9%) | 361 (34.1%) | | 45–59 | 210 (66.5%) | 106 (33.5%) | | ≥60 | 24 (68.6%) | 11 (31.4%) | | Residence | Rural | 412 (67.0%) | 203 (33.0%) | | Urban | 930 (66.5%) | 418 (33.5%) | | Functional status | Working | 827 (66.3%) | 420 (33.7%) | | Ambulatory | 318 (66.4%) | 161 (33.6%) | | Bedridden | 97 (70.8%) | 40 (29.2%) | | World Health Organization clinical staging | Stage I | 178 (63.1%) | 104 (36.9%) | | Stage II | 251 (61.1%) | 160 (38.9%) | | Stage III | 649 (68.7%) | 296 (31.3%) | | Stage IV | 164 (72.9%) | 61 (27.1%) |
|
|
AIDS: acquired immune deficiency syndrome; ART: antiretroviral therapy; HIV: human immunodeficiency virus; IPT: isoniazid preventive therapy.
|
